SCHEMBL380648

SCHEMBL380648

C1=NCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8763529 0.94
SCHEMBL8983791 0.78
SCHEMBL20411638 0.78
SCHEMBL20411669 0.78
SCHEMBL20411674 0.78
Ammonia Solution, Strong SCHEMBL30893636 0.78
SCHEMBL65257 0.78
SCHEMBL20411704 0.78
SCHEMBL20411652 0.78
Hydrochloric Acid SCHEMBL15415089 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250312467-A1 COMPOUND FOR PREPARATION OF ANTIBODY-PAYLOAD CONJUGATE AND USE THEREOF Research & Business Foundation Sungkyunkwan University (KR) 2025-10-09 US claimed
EP-4585268-A2 SOLID FORMS OF ISOQUINOLINONE DERIVATIVES, PROCESS OF MAKING, COMPOSITIONS COMPRISING, AND METHODS OF USING THE SAME Twelve Therapeutics, Inc. (US) 2025-07-16 EP claimed
US-12296019-B2 Compound for preparation of antibody-payload conjugate and use thereof AbTis Co., Ltd. (KR) 2025-05-13 US claimed
CN-119775125-A Method, device and application for hydroxylation of benzoic acid or benzoic acid derivative 上海盛剑微电子有限公司 2025-04-08 CN claimed
WO-2024149231-A1 PARP7 INHIBITORS AND USES THEREOF Angel Pharmaceutical Co., Ltd. (CN) 2024-07-18 WO claimed
US-20240199648-A1 MAP4K1 INHIBITORS BLUEPRINT MEDICINES CORPORATION 2024-06-20 US claimed
CN-114478519-B Pyrazolopyridine compound or salt thereof, and preparation method and application thereof 励缔(杭州)医药科技有限公司 2024-06-11 CN claimed
CN-114181205-B Pyrazolopyridine compound or salt thereof, and preparation method and application thereof 励缔(杭州)医药科技有限公司 2024-06-11 CN claimed
WO-2024112612-A1 NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF RADIONETICS ONCOLOGY, INC. (US) 2024-05-30 WO claimed
WO-2024109671-A1 CAS9 PROTEIN, VARIANTS, OR HOMOLOGUES THEREOF-SPECIFIC PROTAC DEGRADERS AND USES THEREOF GLUETACS THERAPEUTICS (SHANGHAI) CO., LTD. (CN) 2024-05-30 WO claimed
US-7196103-B2 Indole derivatives as factor Xa inhibitors SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-03-27 US claimed
EP-1156049-B1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them SANOFI AVENTIS (FR) 2005-06-01 EP claimed
EP-1044235-B1 PROCESS TO REDUCE THE AOX LEVEL OF WET-STRENGTH RESINS BY TREATMENT WITH BASE HERCULES INC (US) 2005-05-04 EP claimed
US-20050033049-A1 Indole derivatives as factor Xa inhibitors AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-02-10 US claimed
EP-1479677-A1 New indole derivatives as factor xa inhibitors Aventis Pharma Deutschland GmbH (DE) 2004-11-24 EP claimed
JP-2002539214-A 2002-11-19 JP claimed
US-20020082420-A1 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-06-27 US claimed
EP-1163242-A2 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM Boehringer Ingelheim Pharma KG (DE) 2001-12-19 EP claimed
WO-2000055162-A2 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-21 WO claimed
EP-0491346-B1 Cationic dispersion and process for cationizing finely divided particulate matter HERCULES INC (US) 1995-07-05 EP claimed